The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs

被引:28
作者
Schwebel, Herve J. [1 ]
van Hoogevest, Peter [1 ]
Leigh, Mathew L. S. [1 ]
Kuentz, Martin [2 ]
机构
[1] Phares AG, Muttenz, Switzerland
[2] Univ Appl Sci NW Switzerland, Inst Pharma Technol, CH-4132 Muttenz, Switzerland
关键词
Poorly soluble drugs; biorelevant media; FeSSIF; FaSSIF; apparent solubilizing capacity; BIORELEVANT DISSOLUTION MEDIA; HUMAN GASTROINTESTINAL-TRACT; BILE-SALT; FENOFIBRATE; FORMULATION; ABSORPTION; BIOAVAILABILITY; PREDICTION; LECITHIN; MICELLE;
D O I
10.3109/10837451003664099
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug solubility testing in biorelevant media has become an indispensable tool in pharmaceutical development. Despite this importance, there is still an incomplete understanding of how poorly soluble compounds interact with these media. The aim of this study was to apply the concept of the apparent solubilization capacity to fasted and fed state simulated intestinal fluid (FaSSIF and FeSSIF, respectively). A set of non-ionized poorly soluble compounds was studied in biorelevant media prepared from an instantly dissolving complex (SIF (TM) Powder) at 37 degrees C. The values of the solubilization capacity were different between FaSSIF and FeSSIF but correlated. Drug inclusion into the mixed micelles was highly specific for a given compound. The ratio of the FeSSIF to FaSSIF solubility was in particular considered and discussed in terms of the apparent solubilizing capacity. The apparent solubilization concept appears to be useful for the interpretation of biorelevant solubility tests. Further studies are needed to explore acidic and basic drugs.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 36 条
[1]   Predicting the impact of physiological and biochemical processes on oral drug bioavailability [J].
Agoram, B ;
Woltosz, WS ;
Bolger, MB .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S41-S67
[2]   High throughput solubility measurement in drug discovery and development [J].
Alsenz, Jochem ;
Kansy, Manfred .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :546-567
[3]   Development of a partially automated solubility screening (PASS) assay for early drug development [J].
Alsenz, Jochem ;
Meister, Eva ;
Haenel, Elisabeth .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (07) :1748-1762
[4]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[5]   SOLUBILIZATION AND WETTING EFFECTS OF BILE-SALTS ON THE DISSOLUTION OF STEROIDS [J].
BAKATSELOU, V ;
OPPENHEIM, RC ;
DRESSMAN, JB .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1461-1469
[6]   High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media [J].
Bard, Bruno ;
Martel, Sophie ;
Carrupt, Pierre-Alain .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 33 (03) :230-240
[7]   Instant FaSSIF and FeSSIF-Biorelevance Meets Practicality [J].
Boni, Julia Elisabeth ;
Brickl, Rolf Stefan ;
Dressman, Jennifer ;
Pfefferle, Martin L. .
DISSOLUTION TECHNOLOGIES, 2009, 16 (03) :41-45
[8]   Chirality, twist and structures of micellar lyotropic cholesteric liquid crystals in comparison to the properties of chiralic thermotropic phases [J].
Dörfler, HD .
ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2002, 98 (03) :285-340
[9]   Estimating drug solubility in the gastrointestinal tract [J].
Dressman, J. B. ;
Vertzoni, M. ;
Goumas, K. ;
Reppas, C. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :591-602
[10]   Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties [J].
Ertl, P ;
Rohde, B ;
Selzer, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) :3714-3717